RESULTS OF ACCORD 12 TRIAL IN RECTAL CANCER

被引：0
|
作者：
Gerard, J. P. [1 ]
Gourgou-Bourgade, S. [2 ]
Azria, O. [3 ]
Martel-Lafay, L. [4 ]
Hennequin, C. [5 ]
Conroy, T. [6 ]
机构：
[1] Ctr Antoine Lacassagne, Dept Radiotherapy, Nice, France
[2] Ctr Val dAurelle, Biostat, Montpellier, France
[3] Ctr Val dAurelle, Dept Radiotherapy, Montpellier, France
[4] Ctr Leon Berard, Serv Radiotherapie, Lyon, France
[5] CHU St Louis, Serv Radiotherapie, Paris, France
[6] Ctr Alexis Vautrin, Dept Med Oncol, Nancy, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
274
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [31] Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
    Azria, D.
    Doyen, J.
    Jarlier, M.
    Martel-Lafay, I.
    Hennequin, C.
    Etienne, P.
    Vendrely, V.
    Francois, E.
    de la Roche, G.
    Bouche, O.
    Mirabel, X.
    Denis, B.
    Mineur, L.
    Berdah, J.
    Mahe, M.
    Becouran, Y.
    Dupuis, O.
    Lledo, G.
    Seitz, J.
    Bedenne, L.
    Gourgou-Bourgade, S.
    Juzyna, B.
    Conroy, T.
    Gerard, J.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2436 - 2442
  • [32] Rectal cancer:: treatment and results
    Pérez, PL
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2001, 53 (01): : 65 - 76
  • [33] Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: Tolerance and efficacy
    Francois, Eric
    Azria, David
    Gourgou-Bourgade, Sophie
    Jarlier, Marta
    Martel-Laffay, Isabelle
    Hennequin, Christophe
    Etienne, Pierre-Luc
    Vendrely, Veronique
    Seitz, Jean-Francois
    Conroy, Thierry
    Juzyna, Beata
    Gerard, Jean-Pierre
    RADIOTHERAPY AND ONCOLOGY, 2014, 110 (01) : 144 - 149
  • [34] Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.
    Edeline, Julien
    Bonnetain, Franck
    Phelip, Jean Marc
    Watelet, Jerome
    Hammel, Pascal
    Joly, Jean-Paul
    Ben Abdelghani, Meher
    Rosmorduc, Olivier
    Bouhier-Leporrier, Karine
    Jouve, Jean-Louis
    Faroux, Roger
    Meyer, Veronique Guerin
    Assenat, Eric
    Seitz, Jean Francois
    Malka, David
    Louvet, Christophe
    Bertaut, Aurelie
    Juzyna, Beata
    Stanbury, Trevor
    Boucher, Eveline
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [35] FINAL RESULTS OF RANDOMIZED TRIAL ON ADJUVANT CHEMOTHERAPY AFTER PREOPERATIVE CHEMORADIATION IN RECTAL CANCER
    Cionini, L.
    Sainato, A.
    De Paoli, A.
    Osti, M. F.
    Lupattelli, M.
    Vidali, C.
    Turcato, G.
    Galardi, A.
    Ponticelli, P.
    Friso, M. L.
    Dal Fior, S.
    Valentini, V.
    Orlandini, L. C.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S113 - S114
  • [36] Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results
    Czito, Brian G.
    Bendell, Johanna C.
    Willett, Christopher G.
    Morse, Michael A.
    Blobe, Gerard C.
    Tyler, Douglas S.
    Thomas, John
    Ludwig, Kirk A.
    Mantyh, Christopher R.
    Ashton, Jill
    Yu, Daohai
    Hurwitz, Herbert I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (02): : 472 - 478
  • [37] Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial
    Bosset, JF
    Magnin, V
    Maingon, P
    Mantion, G
    Pelissier, EP
    Mercier, M
    Chaillard, G
    Horiot, JC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (02): : 323 - 327
  • [38] Transanal versus abdominal low rectal dissection for rectal cancer: long-term results of the Bordeaux’ randomized trial
    Quentin Denost
    Paula Loughlin
    Remy Chevalier
    Bertrand Celerier
    Romain Didailler
    Eric Rullier
    Surgical Endoscopy, 2018, 32 : 1486 - 1494
  • [39] Transanal versus abdominal low rectal dissection for rectal cancer: long-term results of the Bordeaux' randomized trial
    Denost, Quentin
    Loughlin, Paula
    Chevalier, Remy
    Celerier, Bertrand
    Didailler, Romain
    Rullier, Eric
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (03): : 1486 - 1494
  • [40] Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ACCORD 11 randomized trial
    Lambert, Aurelien
    Jarlier, Marta
    Bourgade, Sophie Gourgou
    Conroy, Thierry
    PLOS ONE, 2017, 12 (09):
12345